Opioid selective antinociception following microinjection into the periaqueductal gray of the rat.

[1]  Melissa L. Mehalick,et al.  Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat. , 2013, The journal of pain : official journal of the American Pain Society.

[2]  A. Murphy,et al.  Persistent peripheral inflammation attenuates morphine-induced periaqueductal gray glial cell activation and analgesic tolerance in the male rat. , 2013, The journal of pain : official journal of the American Pain Society.

[3]  M. Morgan,et al.  Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat. , 2012, The journal of pain : official journal of the American Pain Society.

[4]  M. Adler,et al.  Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120. , 2011, Drug and alcohol dependence.

[5]  M. Adler,et al.  Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain. , 2010, Drug and alcohol dependence.

[6]  S. Charlton,et al.  μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization , 2010, Molecular Pharmacology.

[7]  M. Morgan,et al.  Opioid receptor internalization contributes to dermorphin-mediated antinociception , 2010, Neuroscience.

[8]  M. Bruchas,et al.  Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling , 2010, Proceedings of the National Academy of Sciences.

[9]  M. Morgan,et al.  Drug dependent sex-differences in periaqueducatal gray mediated antinociception in the rat , 2009, PAIN®.

[10]  M. Morgan,et al.  Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat , 2009, Brain Research.

[11]  S. Sirohi,et al.  Dosing protocol and analgesic efficacy determine opioid tolerance in the mouse , 2009, Psychopharmacology.

[12]  Whitney Mcfadden,et al.  Methadone antinociception is dependent on peripheral opioid receptors. , 2009, The journal of pain : official journal of the American Pain Society.

[13]  M. Morgan,et al.  Behavioral Consequences of Delta-Opioid Receptor Activation in the Periaqueductal Gray of Morphine Tolerant Rats , 2009, Neural plasticity.

[14]  A. Murphy,et al.  The Role of the Periaqueductal Gray in the Modulation of Pain in Males and Females: Are the Anatomy and Physiology Really that Different? , 2009, Neural plasticity.

[15]  K. L. Whittier,et al.  Periaqueductal gray neurons project to spinally projecting GABAergic neurons in the rostral ventromedial medulla , 2008, PAIN.

[16]  A. Dahan,et al.  Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone) , 2008, Pain practice : the official journal of World Institute of Pain.

[17]  E. Kalso,et al.  Antinociception by Spinal and Systemic Oxycodone: Why Does the Route Make a Difference?: In Vitro and In Vivo Studies in Rats , 2006, Anesthesiology.

[18]  M. Morgan,et al.  Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat , 2006, Pharmacology Biochemistry and Behavior.

[19]  Tatsuo Yamamoto,et al.  Buprenorphine Activates μ and Opioid Receptor Like-1 Receptors Simultaneously, but the Analgesic Effect Is Mainly Mediated by μ Receptor Activation in the Rat Formalin Test , 2006, Journal of Pharmacology and Experimental Therapeutics.

[20]  M. Morgan,et al.  Morphine antinociceptive potency on chemical, mechanical, and thermal nociceptive tests in the rat. , 2006, The journal of pain : official journal of the American Pain Society.

[21]  M. Glass,et al.  Differential activation of G‐proteins by μ‐opioid receptor agonists , 2006, British journal of pharmacology.

[22]  M. Morgan,et al.  Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats , 2005, Neuroscience.

[23]  G. Pasternak,et al.  Identification of Four Novel Exon 5 Splice Variants of the Mouse μ-Opioid Receptor Gene: Functional Consequences of C-Terminal Splicing , 2005, Molecular Pharmacology.

[24]  G. Pasternak,et al.  Functional analysis of MOR‐1 splice variants of the mouse mu opioid receptor gene Oprm , 2004, Synapse.

[25]  P. Mantegazza,et al.  Periaqueductal gray matter involvement in the muscimol-induced decrease of morphine antinociception , 1982, Naunyn-Schmiedeberg's Archives of Pharmacology.

[26]  F Ivy Carroll,et al.  Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors , 2003, The Journal of Neuroscience.

[27]  D. Selley,et al.  Effect of strain and sex on μ opioid receptor-mediated G-protein activation in rat brain , 2003, Brain Research Bulletin.

[28]  K. Franklin,et al.  The role of descending fibers from the rostral ventromedial medulla in opioid analgesia in rats. , 2002, European journal of pharmacology.

[29]  S. Aicher,et al.  Presynaptic localization of the carboxy-terminus epitopes of the μ opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord , 2001, Neuroscience.

[30]  P. Sánchez-Blázquez,et al.  Agonists determine the pattern of G-protein activation in μ-opioid receptor-mediated supraspinal analgesia , 2001, Brain Research Bulletin.

[31]  R. Gomez-flores,et al.  Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. , 2000, Immunopharmacology.

[32]  R. Bodnar,et al.  Analysis of sex and gonadectomy differences in beta-endorphin antinociception elicited from the ventrolateral periaqueductal gray in rats. , 2000, European journal of pharmacology.

[33]  R. Bodnar,et al.  Actions of NMDA and cholinergic receptor antagonists in the rostral ventromedial medulla upon β-endorphin analgesia elicited from the ventrolateral periaqueductal gray , 1999, Brain Research.

[34]  R. Bodnar,et al.  Morphine antinociception elicited from the ventrolateral periaqueductal gray is sensitive to sex and gonadectomy differences in rats , 1999, Brain Research.

[35]  M. Gold,et al.  Immobility and flight associated with antinociception produced by activation of the ventral and lateral/dorsal regions of the rat periaqueductal gray 1 Published on the World Wide Web on 24 July 1998. 1 , 1998, Brain Research.

[36]  P. Sánchez-Blázquez,et al.  Influence of Gz and Gi2 transducer proteins in the affinity of opioid agonists to μ receptors , 1998, The European journal of neuroscience.

[37]  R. Craft,et al.  Sex differences in opioid antinociception. , 1997, The Journal of pharmacology and experimental therapeutics.

[38]  G. Pasternak,et al.  Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor , 1995, FEBS letters.

[39]  A. Duttaroy,et al.  The Effect of Intrinsic Efficacy on Opioid Tolerance , 1995, Anesthesiology.

[40]  R. Raffa,et al.  The ‘glibenclamide-shift’ of centrally-acting antinociceptive agents in mice , 1995, Brain Research.

[41]  S. Kato,et al.  Location of Regions of the Opioid Receptor Involved in Selective Agonist Binding (*) , 1995, The Journal of Biological Chemistry.

[42]  J. Baeyens,et al.  Subgroups among μ‐opioid receptor agonists distinguished by ATP‐sensitive K+ channel‐acting drugs , 1995, British journal of pharmacology.

[43]  A. Zimprich,et al.  Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1 , 1995, FEBS letters.

[44]  A. Somogyi,et al.  The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model. , 1994, The Journal of pharmacology and experimental therapeutics.

[45]  P. Sánchez-Blázquez,et al.  Dissimilar efficacy of opioids to produce mu-mediated analgesia: role of Gx/z and Gi2 transducer proteins. , 1994, Life sciences.

[46]  G. Pasternak,et al.  Synergistic analgesic interactions between the periaqueductal gray and the locus coeruleus , 1991, Brain Research.

[47]  H. Loh,et al.  Molecular characterization of opioid receptors. , 1990, Annual review of pharmacology and toxicology.

[48]  G. Pasternak,et al.  Role of μ 1-opiate receptors in supraspinal opiate analgesia: a microinjection study , 1988, Brain Research.

[49]  G. Pasternak,et al.  Morphine-6-glucuronide, a potent mu agonist. , 1987, Life sciences.

[50]  M. Ossipov,et al.  Feline analgesia following central administration of opioids , 1984, Neuropharmacology.

[51]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[52]  J. Olley,et al.  INVOLVEMENT OF THE MEDIAN RAPHE NUCLEUS IN ANTINOCICEPTION INDUCED BY MORPHINE, BUPRENORPHINE AND TILIDINE IN THE RAT , 1982, British journal of pharmacology.

[53]  Tony L. Yaksh,et al.  Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques , 1977, Pain.

[54]  A. Lajtha,et al.  Paradoxical Effects after Microinjection of Morphine in the Periaqueductal Gray Matter in the Rat , 1974, Science.